🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Regular dosage of PD

Found 21 matching trials

Study of Comprehension and Execution of Medication Prescriptions in Parkinsonian Patients and Healthy Volunteers

Many patients with Parkinson's disease (Pd) don't respect medication prescr...

Status

Completed

Location

CHU Amiens-Picardie

Start Date

2018-06-15

Trial ID

NCT03976505

Treatments Being Tested

reading a table format prescription on a touch screen reading a textual format prescription on a touch screen filling a virtual pillbox displayed on the screen as prescribed in the prescription eye-tracker cognitive tests and questionary

A Study Assessing HMB-002 in Participants With Von Willebrand Disease

PHASE1

This is a first-in-human (FIH), Phase 1/2, 3-part open-label, dose escalati...

Status

Recruiting

Location

Phoenix Children's Hospital

Start Date

2025-02-06

Trial ID

NCT06754852

Treatments Being Tested

HMB-002 (Part A)HMB-002 (Part B)HMB-002 with Concomitant Factor Concentrate (Part C) (Not Applicable in US)

Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)

This phase II trial studies how well radical-dose image guided radiation th...

Status

Completed

Location

Stanford University, School of Medicine

Start Date

2017-06-28

Trial ID

NCT03176173

Treatments Being Tested

Image-guided Radiation Therapy Immunotherapy (physician's choice for standard of care immunotherapy)

A Clinical Study Evaluating the Safety and Preliminary Efficacy of Universal Allogeneic CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C)in Patients With Refractory Primary Immune Thrombocytopenia

EARLY_PHASE1

This is an investigator-initiated trial to evaluate the safety and efficacy...

Status

Not Yet Recruiting

Location

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Start Date

2026-02-20

Trial ID

NCT07416032

Treatments Being Tested

QT-019C

Tolerability and Efficacy of UV1 Vaccine in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Planned for First-line Treatment With Pembrolizumab

PHASE2

The primary objective of this study is to determine the clinical performanc...

Status

Unknown

Location

Universitätsklinikum Aachen, Klinik für Hämatologie, Onkologie, Hämostaseologie

Start Date

2021-08-02

Trial ID

NCT05075122

Treatments Being Tested

UV1 Sargramostim for Injection Pembrolizumab injection

Observational Study of the Use of Extraneal in Peritoneal Dialysis in Patients

N/A

The purpose of this study is to evaluate the effectiveness and safety of ic...

Status

Completed

Location

Beijing Haidian Hospital

Start Date

2024-06-28

Trial ID

NCT06492031

Treatments Being Tested

Icodextrin Peritoneal Dialysis Solution Glucose Peritoneal Dialysis Solution

MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtib

PHASE2

Osimertinib is an epidermal growth factor receptor tyrosine kinase inhibito...

Status

Unknown

Location

CHU d'ANGERS

Start Date

2019-04-09

Trial ID

NCT03865511

Treatments Being Tested

TAGRISSO® 80mg (Osimertinib)Tumor biopsies ctDNA analysis

Safety and Efficacy Study of Roxadustat (FG-4592) for the Treatment of Anemia in End-Stage Renal Disease (ESRD) Newly Initiated Dialysis Participants

PHASE3

The purpose of this study is to determine whether roxadustat is safe and ef...

Status

Completed

Location

Investigational Site

Start Date

2014-02-11

Trial ID

NCT02052310

Treatments Being Tested

Roxadustat Epoetin Alfa

Differences Between Patients With Vascular Parkinsonism and Parkinson's Disease

N/A

Vascular parkinsonism (VP) is defined as the presence of parkinsonian syndr...

Status

Completed

Location

Ain Shams University

Start Date

2019-09-01

Trial ID

NCT04308135

Treatments Being Tested

Neuro-radiological tools:cognitive tests lab investigations Beck depression inventory (BDI)(Arabic version)Clinical Tools for Urinary symptoms:Freezing of gait questionnaire non-motor symptoms scales (NMSS).Movement Disorders Society- Unified Parkinson's Disease Rating Scale (MDS-UPDRS):ELIZA for alpha-synuclein transcranial color-coded duplex(TCCD)extracranial carotid duplex The Arabic version of Parkinson's Disease Questionnaire( PDQ-39)

Comparision of Pharmacokinetics(PK) and Pharmacodynamics(PD) of Biocon Insulin R and Humulin® R

PHASE1

Single-centre, randomised, double-blind, single dose, two-treatment, two-pe...

Status

Completed

Location

Profil Mainz GmbH

Start Date

2019-06-18

Trial ID

NCT04022317

Treatments Being Tested

Biocon Insulin R Humulin®R

Previous Next